Strain Information | |
---|---|
Image | |
BRC No. | RBRC02725 |
Type | Targeted Mutation Congenic![]() |
Species | Mus musculus |
Strain name | B6.Cg-Gpr89<tm1> |
Former Common name | Gphrloxp<+/-> |
H-2 Haplotype | |
ES Cell line | EGR-G01 [129S2 x C57BL/6NCr-Tg(CAG/Acr-EGFP)] |
Background strain | C57BL/6JJcl |
Appearance | |
Strain development | |
Strain description | |
Colony maintenance | |
References | GPHR-dependent functions of the Golgi apparatus are essential for the formation of lamellar granules and the skin barrier. Tarutani M, Nakajima K, Uchida Y, Takaishi M, Goto-Inoue N, Ikawa M, Setou M, Kinoshita T, Elias P M, Sano S, Maeda Y J. Invest. Dermatol. 132(8):2019-25 (2012). 22572823 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Frt | yeast FRT (flippase recombination target) site | 3 | Frt | ||||
Frt | yeast FRT (flippase recombination target) site | 3 | Frt | ||||
Gpr89 MGI:1914799 | G protein-coupled receptor 89 | 3 | Gpr89<tm1Ymae> | targeted mutation 1, Yusuke Maeda | |||
loxP | phage P1 loxP | 3 | loxP | ||||
loxP | phage P1 loxP | 3 | loxP | ||||
neo | neomycin resistance gene (E. coli) | 3 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 11 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Phage P1 loxP sites, Yeast FRT (flipase recombinant target) sites, mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, Mouse Gpr89 genomic DNA, [CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA), yeast FLPe cDNA] |
Research application | Cre/loxP system FLP/frt system |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Invest. Dermatol., 132, 2019-2025 (2012). The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use with the results from the use. |
Depositor | Taroh Kinoshita (Osaka University) |
Strain Status | ![]() |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |